
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported financial results for the second quarter after the market close on Monday. Here’s a rundown of the report.
- Q2 Revenue: $2.97 billion versus estimates of $2.90 billion
- Q2 Adjusted EPS: $4.52, versus estimates of $4.29